Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer? Reply

被引：1
|
作者：
Dowsett, M [1 ]
Cuzick, J
Wale, C
Howell, T
Houghton, J
Baum, M
Buzdar, A
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England
[3] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[4] UCL Hosp NHS Trust, London, England
[5] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 09期
关键词：
D O I：
10.1200/JCO.2005.05.1623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1482 / 1482
页数：1
相关论文
共 50 条
  • [1] Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer?
    Ponzone, R
    Maggiorotto, F
    Robba, C
    Fuso, L
    Sismondi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1481 - 1482
  • [2] Advances in Variations of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor-2 Status in Metastatic Breast Cancer
    Yuan Yuan
    Zhang Lili
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (02): : 55 - 60
  • [3] The clinical benefit of epidermal growth factor receptor and human epidermal growth factor receptor 2 targeted agents adding to endocrine therapy in hormone receptor-positive breast cancer
    Li, Huan
    Zhai, Qing
    Yu, Bo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S218 - S223
  • [4] Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Adarsh Verma
    Amrita Ghosh Kar
    Ram Niwas Meena
    S. C. U. Patne
    Shashi Prakash Mishra
    Seema Khanna
    Rahul Khanna
    Indian Journal of Surgery, 2021, 83 : 399 - 403
  • [5] Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Verma, Adarsh
    Kar, Amrita Ghosh
    Meena, Ram Niwas
    Patne, S. C. U.
    Mishra, Shashi Prakash
    Khanna, Seema
    Khanna, Rahul
    INDIAN JOURNAL OF SURGERY, 2021, 83 (SUPPL 2) : 399 - 403
  • [6] Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy
    Ishitobi, Makoto
    Shiba, Mizuho
    Nakayama, Takahiro
    Koyama, Hiroki
    Tamaki, Yasuhiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 843 - 846
  • [7] Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors
    Huszno, Joanna
    Nowara, Elibieta
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 307 - 311
  • [8] Association of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression with Breast Cancer Metastasis in Iran
    Jafari, Seyed Hamed
    Jahanmir, Armaghan
    Bahramvand, Yaser
    Tahmasebi, Sedigheh
    Dallaki, Manoochehr
    Nasrollahi, Elham
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2022, 47 (01) : 40 - 47
  • [9] Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer
    Asogan, Aravind Barathi
    Hong, Ga Sze
    Prabhakaran, Subash Kumar Arni
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (03) : 145 - 149
  • [10] Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
    Panahi, Marzieh
    Saki, Najmaldin
    Ashourzadeh, Sara
    Rahim, Fakher
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3699 - 3703
12345